Translate Bio

$18.84
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

-$0.84 (-4.27%) Today
$0.00 (0.00%) As of 8:17 PM UTC after-hours

Why Robinhood?

You can buy or sell Translate Bio and other stocks, options, and ETFs commission-free!

About TBIO

Translate Bio, Inc. engages in the research and development of therapeutic drugs. It focuses on developing medicines to treat diseases caused by protein or gene dysfunction.

CEO
Ronald C. Renaud
Employees
122
Headquarters
Lexington, Massachusetts
Founded
2011
Market Cap
1.30B
Price-Earnings Ratio
—
Dividend Yield
—
Average Volume
1.38M
High Today
$19.71
Low Today
$18.61
Open Price
$19.51
Volume
1.07M
52 Week High
$34.64
52 Week Low
$9.64

TBIO Earnings

-$0.58
-$0.31
-$0.04
$0.23
Q3 FY19
Q4 FY19
Q1 FY20
Q2 FY20
Q3 FY20
Q4 FY20
Q1 FY21
Estimated
— per share
Actual
Expected May 6, After Hours

You May Also Like

SLF
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, a registered broker-dealer and Member SIPC. Full disclosure